Strategic Diagnostics Inc. (SDIX)
-NasdaqGM 0.98 0.00(0.00%) 3:23PM EDT
| Prev Close: | 0.98 |
|---|
| Open: | 0.98 |
|---|
| Bid: | 0.00 x 1000 |
|---|
| Ask: | 1.00 x 1300 |
|---|
| 1y Target Est: | 4.97 |
|---|
| Beta: | 0.15 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.96 - 0.98 |
|---|
| 52wk Range: | 0.87 - 1.50 |
|---|
| Volume: | 19,269 |
|---|
| Avg Vol (3m): | 38,994 |
|---|
| Market Cap: | 20.69M |
|---|
| P/E (ttm): | 5.27 |
|---|
| EPS (ttm): | 0.19 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- STRATEGIC DIAGNOSTICS INC/DE/ FinancialsEDGAR Online Financials(Sat, Jun 15)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim ReviewEDGAR Online(Tue, Jun 11)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- Egalet Appoints Stan Musial as CFOPR Newswire(Wed, May 8)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-K, Annual ReportEDGAR Online(Mon, Apr 15)
- China Biotech In Review: Lilly Invests $100 Million In China Animal Healthcareat Seeking Alpha(Sun, Apr 14)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors orEDGAR Online(Wed, Apr 10)
- OriGene to Acquire SDIX's Life Science Business AssetsPR Newswire(Mon, Apr 8)
- SDIX Sells Life Science Assets to OriGene Technologies, Inc. for $16 MillionBusiness Wire(Mon, Apr 8)
- SDIX trading halted, pending newstheflyonthewall.com(Mon, Apr 8)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Termination of a Material Definitive AgreementEDGAR Online(Wed, Nov 28)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, Nov 14)
- STRATEGIC DIAGNOSTICS INC/DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial StatementsEDGAR Online(Tue, Nov 13)
- SDIX Reports Third Quarter 2012 ResultsBusiness Wire(Mon, Nov 12)
- SDIX to Report Third Quarter 2012 Results on November 12, 2012Business Wire(Mon, Nov 5)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.43 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(0-00-31)
: | N/A |
|---|
| Quarterly EPS Est
(0-00-31)
: | N/A |
|---|
| Mean Recommendation*: | N/A |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Strategic Diagnostics Inc., a biotechnology company, develops, commercializes, and markets proprietary products, services, and solutions for human health and wellness in the United States and internationally.
View More 
0.91%